CardioCompass

Transforming Cardiovascular Care at Population Scale

Revolutionizing Remote Care for Mass General Brigham

We partnered with Brigham and Women’s Hospital’s Cardiovascular Medicine Innovation team to architect and build CardioCompass, a groundbreaking remote cardiovascular management platform that has redefined how chronic conditions are managed at scale. This algorithm-driven system empowers navigators and pharmacists to optimize medications for hypertension and cholesterol management without requiring traditional office visits.

The Challenge

Healthcare systems nationwide struggle with a critical gap: 30-50% of cardiovascular patients never achieve optimal treatment despite proven therapies being readily available. Traditional care models requiring frequent in-person visits create barriers to medication optimization, leading to preventable heart attacks, strokes, and deaths.

Our Solution

We engineered a sophisticated remote care platform that:

• Integrates seamlessly with Mass General Brigham’s electronic health records for population-level screening and enrollment
• Automates clinical algorithms to guide evidence-based medication titration decisions
• Enables secure, HIPAA-compliant communication between patients and care navigators via text and email
• Processes real-time data streams from connected blood pressure monitors and laboratory systems
• Scales effortlessly to support thousands of concurrent patients across diverse populations

The Impact

Our platform has delivered transformative results:

• 10,000+ patients successfully enrolled and managed remotely
• 424,000+ blood pressure readings collected and analyzed in real-time
• 4X more effective than traditional patient education programs in reducing cardiovascular risk
• 10 mmHg systolic blood pressure reduction at 12 months for actively managed patients
• 25% surge in enrollment during COVID-19, proving essential for care continuity
• 93 mg/dL average cholesterol reduction in highest-risk patients

Published Research & Clinical Validation

The clinical outcomes and innovations of CardioCompass have been independently validated and published in leading peer-reviewed medical journals:

These peer-reviewed publications establish CardioCompass as a model for remote chronic disease management nationwide. The platform demonstrates how thoughtfully designed technology can bridge the gap between clinical guidelines and real-world practice, ultimately saving lives at scale.